Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Petter Bjornstad

Concepts (394)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Diabetic Nephropathies
76
2025
278
24.750
 Why?
Diabetes Mellitus, Type 2
67
2025
2428
10.890
 Why?
Diabetes Mellitus, Type 1
78
2025
3625
10.220
 Why?
Glomerular Filtration Rate
62
2025
682
8.600
 Why?
Kidney
50
2025
1306
6.420
 Why?
Uric Acid
23
2022
160
4.750
 Why?
Albuminuria
23
2024
181
4.290
 Why?
Insulin Resistance
20
2024
1164
4.260
 Why?
Renal Insufficiency, Chronic
19
2025
562
3.290
 Why?
Hemodynamics
23
2025
1077
2.920
 Why?
Pediatric Obesity
8
2023
570
2.880
 Why?
Metformin
12
2025
312
2.850
 Why?
Renal Insufficiency
6
2023
148
2.790
 Why?
Coronary Artery Disease
11
2022
675
2.590
 Why?
Biomarkers
36
2025
3874
2.510
 Why?
Diabetic Angiopathies
9
2019
261
2.470
 Why?
Glycopeptides
10
2021
44
2.290
 Why?
Bariatric Surgery
5
2020
192
2.270
 Why?
Obesity, Morbid
5
2020
239
2.200
 Why?
Vascular Calcification
6
2022
107
2.170
 Why?
Hypoglycemic Agents
20
2025
1212
2.130
 Why?
Adolescent
64
2025
20158
2.080
 Why?
Renin-Angiotensin System
10
2021
79
1.980
 Why?
Sodium-Glucose Transporter 2
12
2024
22
1.940
 Why?
Humans
167
2025
128020
1.800
 Why?
Sex Characteristics
6
2025
719
1.680
 Why?
Cardiovascular Diseases
15
2024
1994
1.670
 Why?
Creatinine
18
2025
478
1.650
 Why?
Young Adult
45
2025
12282
1.620
 Why?
Male
99
2025
62758
1.500
 Why?
Disease Progression
19
2024
2598
1.450
 Why?
Diabetic Ketoacidosis
3
2024
197
1.450
 Why?
Female
94
2025
68017
1.390
 Why?
Glucosides
9
2025
38
1.360
 Why?
Benzhydryl Compounds
9
2025
66
1.330
 Why?
Calcinosis
4
2015
230
1.330
 Why?
Obesity
12
2025
2859
1.290
 Why?
Adult
59
2025
35177
1.260
 Why?
Kidney Diseases
3
2023
370
1.210
 Why?
Diabetic Cardiomyopathies
4
2020
34
1.190
 Why?
Risk Factors
36
2024
9696
1.140
 Why?
Child
33
2025
20636
1.080
 Why?
Adiposity
5
2024
504
1.040
 Why?
Arterioles
3
2024
41
1.010
 Why?
Hypertension
9
2021
1234
1.010
 Why?
Follow-Up Studies
17
2025
4853
0.990
 Why?
Exercise Tolerance
3
2017
271
0.980
 Why?
Fructose
4
2021
106
0.970
 Why?
Atherosclerosis
4
2018
403
0.960
 Why?
Apolipoproteins B
2
2015
43
0.960
 Why?
Vascular Stiffness
7
2022
463
0.950
 Why?
Cross-Sectional Studies
19
2025
5034
0.940
 Why?
Body Composition
3
2025
644
0.940
 Why?
Uromodulin
3
2019
21
0.930
 Why?
Proteinuria
2
2024
88
0.930
 Why?
Hyperglycemia
5
2024
326
0.920
 Why?
Hyperuricemia
6
2021
44
0.920
 Why?
Middle Aged
50
2025
30813
0.920
 Why?
Vasopressins
3
2023
64
0.910
 Why?
Case-Control Studies
14
2025
3324
0.910
 Why?
Immunoglobulin Fc Fragments
1
2024
40
0.900
 Why?
Adiponectin
2
2016
234
0.890
 Why?
Glucagon-Like Peptides
1
2024
49
0.870
 Why?
Acute Kidney Injury
5
2024
777
0.870
 Why?
Hyperoxia
1
2024
87
0.830
 Why?
Prognosis
11
2025
3766
0.830
 Why?
Diabetic Retinopathy
4
2021
172
0.820
 Why?
Iothalamic Acid
1
2022
5
0.820
 Why?
Kidney Tubules
2
2021
114
0.820
 Why?
Dyslipidemias
5
2021
176
0.820
 Why?
Blood Glucose
11
2025
2092
0.810
 Why?
Cystatin C
8
2023
65
0.780
 Why?
Epithelial-Mesenchymal Transition
1
2024
201
0.780
 Why?
Kidney Glomerulus
5
2023
107
0.760
 Why?
Glucagon-Like Peptide-1 Receptor
6
2024
91
0.750
 Why?
Recombinant Fusion Proteins
1
2024
634
0.750
 Why?
Bone Density
1
2025
474
0.720
 Why?
Polycystic Kidney, Autosomal Dominant
1
2024
223
0.700
 Why?
Oxygen Consumption
3
2017
669
0.670
 Why?
Dried Blood Spot Testing
2
2018
91
0.670
 Why?
Kidney Failure, Chronic
4
2023
540
0.660
 Why?
Iohexol
2
2020
18
0.660
 Why?
Triglycerides
3
2022
523
0.650
 Why?
Blood Pressure
9
2022
1711
0.650
 Why?
Oxygen
2
2024
899
0.650
 Why?
Vascular Resistance
6
2020
366
0.640
 Why?
Longevity
6
2022
149
0.630
 Why?
Pilot Projects
7
2024
1559
0.630
 Why?
Cyclic GMP
1
2019
85
0.630
 Why?
Coronary Vessels
3
2017
236
0.620
 Why?
Lipid Metabolism Disorders
1
2018
2
0.620
 Why?
Cohort Studies
18
2025
5378
0.610
 Why?
Leptin
2
2017
218
0.600
 Why?
Overweight
3
2025
522
0.590
 Why?
Weight Reduction Programs
1
2019
111
0.590
 Why?
Gastric Bypass
1
2020
107
0.590
 Why?
Cardiotonic Agents
1
2018
124
0.590
 Why?
Hemofiltration
1
2018
30
0.580
 Why?
Sodium Bicarbonate
1
2018
37
0.580
 Why?
Cholesterol, HDL
2
2015
203
0.570
 Why?
Incidence
9
2021
2614
0.570
 Why?
Glucose
5
2023
983
0.560
 Why?
Ventricular Function, Left
3
2020
524
0.560
 Why?
Blood Vessels
1
2018
181
0.550
 Why?
Aorta
2
2019
408
0.540
 Why?
Up-Regulation
2
2016
822
0.520
 Why?
Nutrition Surveys
1
2017
261
0.510
 Why?
Cholesterol, LDL
2
2014
357
0.500
 Why?
Kidney Function Tests
4
2022
145
0.490
 Why?
Renal Circulation
3
2021
57
0.480
 Why?
Canada
7
2022
344
0.470
 Why?
Angiotensin II Type 2 Receptor Blockers
1
2014
7
0.460
 Why?
Aged
28
2025
21892
0.460
 Why?
Pregnancy Outcome
1
2017
389
0.460
 Why?
Body Mass Index
9
2025
2260
0.460
 Why?
Fasting
2
2025
264
0.450
 Why?
Hypoxia
2
2020
1034
0.450
 Why?
Echocardiography
2
2018
623
0.440
 Why?
Dietary Supplements
1
2018
531
0.430
 Why?
Goals
1
2015
160
0.420
 Why?
Drug Therapy, Combination
5
2025
1012
0.420
 Why?
Patient Care Planning
1
2014
148
0.420
 Why?
Vasoconstriction
3
2020
185
0.420
 Why?
Brain
1
2025
2615
0.410
 Why?
Heart Failure
3
2021
2141
0.410
 Why?
Lipids
2
2022
619
0.400
 Why?
Chitinase-3-Like Protein 1
2
2022
19
0.400
 Why?
Sodium
4
2023
202
0.390
 Why?
Contrast Media
1
2015
387
0.390
 Why?
Histidine
2
2022
58
0.390
 Why?
Age of Onset
2
2025
490
0.380
 Why?
Glucose Clamp Technique
5
2020
194
0.370
 Why?
Albumins
3
2022
101
0.360
 Why?
Clinical Trials as Topic
6
2022
997
0.360
 Why?
Angiotensin II
3
2020
93
0.360
 Why?
Insulin
6
2024
2316
0.350
 Why?
Guideline Adherence
1
2015
523
0.350
 Why?
Absorptiometry, Photon
2
2025
248
0.340
 Why?
Lipocalin-2
2
2022
75
0.340
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
410
0.330
 Why?
Prospective Studies
9
2025
7035
0.330
 Why?
Testosterone
3
2025
369
0.320
 Why?
Running
2
2023
222
0.310
 Why?
Pulse Wave Analysis
5
2022
246
0.300
 Why?
Diabetes Complications
2
2021
223
0.290
 Why?
Animals
15
2024
34487
0.280
 Why?
Metabolic Syndrome
3
2021
338
0.280
 Why?
Epidermal Growth Factor
2
2024
170
0.270
 Why?
Canagliflozin
3
2023
9
0.270
 Why?
Treatment Outcome
10
2019
10110
0.270
 Why?
Heat Stress Disorders
2
2018
69
0.260
 Why?
Dipeptidyl-Peptidase IV Inhibitors
3
2025
45
0.260
 Why?
Diabetes Mellitus
3
2021
994
0.260
 Why?
Age Factors
7
2019
3100
0.250
 Why?
Severity of Illness Index
3
2021
2703
0.250
 Why?
Time Factors
6
2018
6479
0.250
 Why?
Colorado
4
2017
4369
0.250
 Why?
Gliclazide
1
2025
2
0.250
 Why?
Linagliptin
1
2025
5
0.240
 Why?
Hydrogen-Ion Concentration
2
2018
541
0.240
 Why?
Leucine
2
2024
108
0.240
 Why?
Predictive Value of Tests
4
2018
1934
0.240
 Why?
Fatty Acid Binding Protein 3
1
2024
5
0.240
 Why?
Vascular Cell Adhesion Molecule-1
1
2024
37
0.230
 Why?
Early Diagnosis
2
2017
234
0.230
 Why?
Citric Acid Cycle
1
2024
50
0.230
 Why?
Estradiol
2
2025
486
0.230
 Why?
Gray Matter
1
2025
82
0.230
 Why?
Renin
2
2022
31
0.230
 Why?
Androgen Antagonists
1
2025
79
0.230
 Why?
Lipoproteins
2
2022
171
0.230
 Why?
Sex Factors
4
2025
1942
0.230
 Why?
Diuretics
2
2023
75
0.230
 Why?
Endothelin Receptor Antagonists
2
2024
61
0.220
 Why?
Mineralocorticoid Receptor Antagonists
2
2024
45
0.220
 Why?
National Institutes of Health (U.S.)
1
2024
122
0.210
 Why?
Receptors, Vasopressin
2
2021
19
0.210
 Why?
Magnetic Resonance Imaging
3
2025
3371
0.210
 Why?
Inappropriate ADH Syndrome
1
2023
8
0.210
 Why?
Cysts
1
2024
108
0.210
 Why?
Hyponatremia
1
2023
40
0.200
 Why?
Fluorocarbons
1
2024
109
0.200
 Why?
Longitudinal Studies
5
2024
2706
0.200
 Why?
Consensus
2
2022
607
0.200
 Why?
Malates
1
2022
5
0.200
 Why?
Fumarates
1
2022
9
0.200
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2023
115
0.200
 Why?
Threonine
1
2022
44
0.200
 Why?
Carboxylic Acids
1
2022
32
0.190
 Why?
Natriuresis
2
2019
10
0.190
 Why?
Diabetes Mellitus, Experimental
1
2023
175
0.190
 Why?
Rats
2
2024
5199
0.190
 Why?
Amino Acids
2
2024
476
0.190
 Why?
Phenylalanine
1
2022
65
0.190
 Why?
Pathology, Clinical
1
2022
36
0.190
 Why?
Chemokine CCL2
1
2022
117
0.190
 Why?
Arizona
1
2021
78
0.180
 Why?
Glycine
1
2022
163
0.180
 Why?
Glucagon-Like Peptide 1
1
2022
112
0.180
 Why?
Oxidation-Reduction
1
2024
1001
0.180
 Why?
Osmolar Concentration
2
2018
165
0.180
 Why?
p-Aminohippuric Acid
1
2020
6
0.180
 Why?
Tryptophan
1
2022
171
0.180
 Why?
Multivariate Analysis
2
2014
1492
0.170
 Why?
Interleukin-18
1
2022
236
0.170
 Why?
Japan
5
2017
96
0.170
 Why?
Nephrosis
1
2020
4
0.170
 Why?
Natriuretic Peptide, Brain
1
2021
99
0.170
 Why?
Furosemide
1
2020
39
0.170
 Why?
Asymptomatic Diseases
2
2019
83
0.170
 Why?
Calcium Channel Blockers
1
2021
123
0.170
 Why?
Diabetic Neuropathies
1
2021
86
0.170
 Why?
Transgender Persons
1
2023
171
0.170
 Why?
Angiotensin-Converting Enzyme Inhibitors
2
2024
198
0.170
 Why?
Sodium-Glucose Transporter 1
1
2019
10
0.160
 Why?
Body Water
1
2019
18
0.160
 Why?
Double-Blind Method
2
2025
1852
0.160
 Why?
Diabetic Foot
1
2019
24
0.160
 Why?
Models, Biological
3
2016
1689
0.160
 Why?
Glycolysis
1
2021
293
0.160
 Why?
Glomerulonephritis
1
2019
46
0.160
 Why?
Glycosides
1
2019
37
0.160
 Why?
Blood Chemical Analysis
1
2019
94
0.160
 Why?
Postmenopause
1
2021
348
0.160
 Why?
beta 2-Microglobulin
1
2018
47
0.150
 Why?
Endothelial Cells
1
2024
700
0.150
 Why?
Myocardial Contraction
1
2020
333
0.150
 Why?
Body Temperature Regulation
1
2019
95
0.150
 Why?
Energy Metabolism
1
2024
831
0.150
 Why?
Microscopy, Polarization
1
2018
31
0.150
 Why?
Carotid Intima-Media Thickness
1
2018
90
0.150
 Why?
Hepatitis A Virus Cellular Receptor 1
1
2018
42
0.150
 Why?
Allopurinol
1
2018
60
0.150
 Why?
Biopsy
1
2022
1077
0.150
 Why?
Weight Loss
2
2020
725
0.150
 Why?
Pharmaceutical Preparations
1
2020
168
0.150
 Why?
Obesity, Metabolically Benign
1
2017
4
0.140
 Why?
Prehypertension
1
2017
27
0.140
 Why?
Glucose Tolerance Test
2
2019
356
0.140
 Why?
Glomerulosclerosis, Focal Segmental
1
2017
42
0.140
 Why?
Life Style
1
2019
459
0.140
 Why?
Hyperthermia, Induced
1
2018
108
0.140
 Why?
Deamino Arginine Vasopressin
1
2016
11
0.140
 Why?
Urinary Calculi
1
2017
11
0.140
 Why?
Gastrointestinal Microbiome
1
2024
631
0.140
 Why?
Precision Medicine
1
2020
384
0.140
 Why?
Tomography, X-Ray Computed
2
2018
2509
0.130
 Why?
Peptide Fragments
1
2021
688
0.130
 Why?
Ventricular Dysfunction, Left
1
2020
383
0.130
 Why?
Disease Models, Animal
5
2021
3936
0.130
 Why?
Magnetic Resonance Angiography
1
2018
235
0.130
 Why?
Blood Banks
1
2016
40
0.130
 Why?
Morbidity
1
2017
301
0.130
 Why?
Dehydration
1
2016
49
0.130
 Why?
Cardiorespiratory Fitness
1
2017
48
0.130
 Why?
Regional Blood Flow
1
2018
457
0.130
 Why?
Vasodilation
1
2020
461
0.130
 Why?
Anti-Inflammatory Agents
1
2020
467
0.130
 Why?
Child, Preschool
3
2024
10378
0.130
 Why?
Mice
4
2023
16574
0.130
 Why?
Cognition
1
2024
1104
0.130
 Why?
Survival Rate
2
2017
1870
0.130
 Why?
Logistic Models
3
2017
1975
0.130
 Why?
Vitreoretinopathy, Proliferative
1
2016
12
0.130
 Why?
Linear Models
2
2017
816
0.130
 Why?
Hot Temperature
1
2018
359
0.120
 Why?
Heart Rate
1
2019
797
0.120
 Why?
Echocardiography, Doppler
1
2016
108
0.120
 Why?
Liver Diseases
1
2018
285
0.120
 Why?
Filtration
1
2015
64
0.120
 Why?
Risk Assessment
4
2019
3223
0.120
 Why?
Software
1
2019
606
0.120
 Why?
Apolipoproteins
1
2014
38
0.120
 Why?
Enzyme Inhibitors
1
2018
809
0.120
 Why?
Blood Pressure Determination
1
2015
148
0.110
 Why?
Purines
1
2015
168
0.110
 Why?
Phenotype
1
2022
3039
0.110
 Why?
Achievement
1
2014
57
0.110
 Why?
Stress, Mechanical
1
2016
460
0.110
 Why?
Immunity, Innate
1
2019
801
0.110
 Why?
Liver
2
2021
1826
0.110
 Why?
Randomized Controlled Trials as Topic
1
2019
1356
0.100
 Why?
Primary Prevention
1
2015
186
0.100
 Why?
Exercise Test
1
2016
613
0.100
 Why?
Research Design
1
2019
1034
0.100
 Why?
Biomechanical Phenomena
1
2016
759
0.100
 Why?
United States
3
2024
13785
0.100
 Why?
Adenosine Triphosphate
1
2015
469
0.100
 Why?
Cholesterol
1
2014
406
0.100
 Why?
Aged, 80 and over
3
2018
7029
0.100
 Why?
Antihypertensive Agents
1
2016
481
0.100
 Why?
RNA, Messenger
1
2019
2669
0.100
 Why?
Proof of Concept Study
2
2024
65
0.090
 Why?
Regression Analysis
1
2014
978
0.090
 Why?
Feasibility Studies
1
2015
860
0.090
 Why?
Exercise
1
2022
1917
0.090
 Why?
Ambulatory Care
1
2015
500
0.090
 Why?
Vascular Diseases
1
2013
232
0.090
 Why?
Societies, Medical
1
2015
741
0.090
 Why?
Hematocrit
2
2021
93
0.090
 Why?
Gene Expression Regulation
1
2019
2508
0.080
 Why?
Practice Guidelines as Topic
1
2017
1482
0.080
 Why?
Retrospective Studies
7
2024
14404
0.080
 Why?
Fructokinases
2
2021
31
0.080
 Why?
Registries
1
2016
1873
0.080
 Why?
Inflammation
2
2021
2646
0.070
 Why?
Prevalence
3
2019
2541
0.070
 Why?
Reproducibility of Results
1
2015
3009
0.070
 Why?
Fibrosis
2
2021
513
0.070
 Why?
Pregnancy
1
2017
6355
0.060
 Why?
Postprandial Period
1
2025
103
0.060
 Why?
Isoleucine
1
2024
14
0.060
 Why?
Mice, Inbred C57BL
3
2021
5268
0.060
 Why?
Valine
1
2024
80
0.050
 Why?
Obesity, Abdominal
1
2024
47
0.050
 Why?
Aging
1
2014
1745
0.050
 Why?
Multicenter Studies as Topic
1
2024
285
0.050
 Why?
RNA, Transfer
1
2024
130
0.050
 Why?
Bromocriptine
1
2022
28
0.050
 Why?
Infant, Newborn
1
2014
5688
0.050
 Why?
Environmental Pollutants
1
2024
142
0.050
 Why?
Benzbromarone
1
2022
3
0.050
 Why?
Aldosterone
1
2022
43
0.050
 Why?
Cytokines
2
2021
1984
0.050
 Why?
Glycoproteins
1
2024
337
0.050
 Why?
Controlled Clinical Trials as Topic
1
2021
27
0.050
 Why?
Adenine
1
2023
255
0.050
 Why?
Clinical Trials, Phase III as Topic
1
2021
92
0.050
 Why?
Inulin
1
2021
7
0.050
 Why?
Hep G2 Cells
1
2021
61
0.040
 Why?
Drinking
1
2021
39
0.040
 Why?
Serum Albumin
1
2021
146
0.040
 Why?
TOR Serine-Threonine Kinases
1
2023
380
0.040
 Why?
Uricosuric Agents
1
2020
2
0.040
 Why?
Diuretics, Osmotic
1
2020
1
0.040
 Why?
Infant
1
2014
8912
0.040
 Why?
Cross-Over Studies
1
2022
507
0.040
 Why?
Mendelian Randomization Analysis
1
2020
46
0.040
 Why?
Environmental Exposure
1
2024
458
0.040
 Why?
Cell Hypoxia
1
2021
228
0.040
 Why?
Diastole
1
2020
148
0.040
 Why?
Chemokines
1
2021
221
0.040
 Why?
Cytoprotection
1
2019
50
0.040
 Why?
Systole
1
2020
190
0.040
 Why?
Netherlands
1
2019
77
0.040
 Why?
Neuropsychological Tests
1
2024
1001
0.040
 Why?
Drug Interactions
1
2021
361
0.040
 Why?
Preoperative Period
1
2019
113
0.040
 Why?
Cognitive Dysfunction
1
2024
343
0.040
 Why?
Magnetic Resonance Imaging, Cine
1
2020
184
0.040
 Why?
Incretins
1
2018
18
0.040
 Why?
Macular Edema
1
2018
42
0.040
 Why?
Photography
1
2018
95
0.040
 Why?
Renal Elimination
1
2018
6
0.040
 Why?
Inflammation Mediators
1
2021
495
0.040
 Why?
Xanthine Oxidase
1
2018
77
0.040
 Why?
HSP70 Heat-Shock Proteins
1
2018
67
0.040
 Why?
Diet Therapy
1
2018
34
0.040
 Why?
Renal Dialysis
1
2021
420
0.040
 Why?
Anti-Obesity Agents
1
2018
53
0.040
 Why?
Cardiovascular System
1
2019
136
0.040
 Why?
Lipoproteins, LDL
1
2017
127
0.030
 Why?
Renal Plasma Flow, Effective
1
2016
1
0.030
 Why?
Tomography, Optical Coherence
1
2018
186
0.030
 Why?
Blood Urea Nitrogen
1
2016
53
0.030
 Why?
Blood Pressure Monitoring, Ambulatory
1
2017
81
0.030
 Why?
Water-Electrolyte Balance
1
2016
32
0.030
 Why?
Thiazolidinediones
1
2018
137
0.030
 Why?
Aldehyde Reductase
1
2016
27
0.030
 Why?
Interleukin-6
1
2021
712
0.030
 Why?
Infusions, Intravenous
1
2018
390
0.030
 Why?
Ammonia
1
2016
62
0.030
 Why?
Proportional Hazards Models
1
2019
1194
0.030
 Why?
Age Distribution
1
2017
369
0.030
 Why?
Sex Distribution
1
2017
356
0.030
 Why?
Collagen
1
2018
429
0.030
 Why?
Waist Circumference
1
2015
138
0.030
 Why?
Combined Modality Therapy
1
2018
1199
0.030
 Why?
Circadian Rhythm
1
2017
409
0.030
 Why?
Blood Glucose Self-Monitoring
1
2019
601
0.030
 Why?
Mice, Knockout
1
2021
2757
0.030
 Why?
Complement Activation
1
2016
365
0.030
 Why?
Exercise Therapy
1
2018
412
0.030
 Why?
Heart Ventricles
1
2018
765
0.030
 Why?
Peptides
1
2018
910
0.020
 Why?
Rats, Sprague-Dawley
1
2017
2258
0.020
 Why?
Gene-Environment Interaction
1
2014
185
0.020
 Why?
Comorbidity
1
2017
1537
0.020
 Why?
Models, Statistical
1
2015
621
0.020
 Why?
Databases, Factual
1
2017
1264
0.020
 Why?
Non-alcoholic Fatty Liver Disease
1
2014
258
0.020
 Why?
Algorithms
1
2015
1609
0.020
 Why?
Hospitalization
1
2017
2057
0.020
 Why?
Neoplasms
1
2014
2460
0.010
 Why?
Bjornstad's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (394) concept(s)
_
Co-Authors Expand Description
See all (66) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)